<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04914819</url>
  </required_header>
  <id_info>
    <org_study_id>844694</org_study_id>
    <nct_id>NCT04914819</nct_id>
  </id_info>
  <brief_title>Postpartum Weight Loss for Women at Elevated Cardiovascular Risk</brief_title>
  <acronym>EMPOWER-Mom</acronym>
  <official_title>Postpartum Weight Loss for Women at Elevated Cardiovascular Risk (EmPOWER-Mom Study)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Pennsylvania</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Pennsylvania</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to test the feasibility and effectiveness of a 16-week online&#xD;
      behavioral weight loss program compared to usual care to promote weight loss in the&#xD;
      postpartum period among women with cardiovascular risk factors. The investigators will also&#xD;
      be testing different behavioral strategies to recruit postpartum women to the study,&#xD;
      including 2 email recruitment strategies and 2 mailer recruitment strategies, informed by&#xD;
      behavioral design.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 18, 2021</start_date>
  <completion_date type="Anticipated">January 2022</completion_date>
  <primary_completion_date type="Anticipated">December 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in weight in pounds from baseline to 16-week follow-up</measure>
    <time_frame>16 weeks</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Enrollment rate between email recruitment strategies</measure>
    <time_frame>8 weeks</time_frame>
    <description>We will compare enrollment rates between two behaviorally-framed email strategies</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Enrollment rate between mailer recruitment strategies</measure>
    <time_frame>8 weeks</time_frame>
    <description>We will compare enrollment rates between the group receiving a mailer versus mailer plus baby gift</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Proportion of participants losing 5 percent or more of weight from baseline to 16-week follow-up</measure>
    <time_frame>16 weeks</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Study completion rate between 2 arms</measure>
    <time_frame>16 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Intervention arm: number of total logins</measure>
    <time_frame>16 weeks</time_frame>
    <description>Engagement with BWL platform measured by total number of logins</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Intervention arm: number of weeks with one or more logins</measure>
    <time_frame>16 weeks</time_frame>
    <description>Engagement with BWL platform measured by number of weeks with one or more logins</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Intervention arm: number of weeks with daily data reporting for at least 5 of 7 days</measure>
    <time_frame>16 weeks</time_frame>
    <description>number of weeks that calories, physical activity minutes, and body weight were reported at least 5 of 7 days</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Weight Loss</condition>
  <condition>Postpartum Weight Retention</condition>
  <condition>Hypertension in Pregnancy</condition>
  <condition>Diabetes Mellitus in Pregnancy</condition>
  <condition>Preeclampsia</condition>
  <condition>Recruitment</condition>
  <arm_group>
    <arm_group_label>Online Behavioral Weight Loss</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Participants will attend a virtual introduction to weight loss session and be enrolled in a 16-week online behavioral weight loss program. Participants will complete a virtual weigh-in at the start and end of the study.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Usual Care</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Participants will complete a virtual weigh-in at the start and end of the study. No additional intervention will be provided.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Online Behavioral Weight Loss Program</intervention_name>
    <description>Participants will be enrolled in a 16-week online behavioral weight loss program based on the Diabetes Prevention Program (DPP). The program involves weekly brief videos, a self-monitoring platform, automated feedback, and access to a health coach.</description>
    <arm_group_label>Online Behavioral Weight Loss</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Virtual weigh-in</intervention_name>
    <description>Participants will be sent a digital scale and will be asked to complete a virtual weigh-in at home at the start of the study and again after 16 weeks.</description>
    <arm_group_label>Online Behavioral Weight Loss</arm_group_label>
    <arm_group_label>Usual Care</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Age ≥18 years;&#xD;
&#xD;
          2. Delivered a baby at HUP or PAH within 3-12 months prior to study start;&#xD;
&#xD;
          3. BMI ≥ 27 kg/m2&#xD;
&#xD;
          4. Diagnosis of one of the following medical conditions: chronic hypertension,&#xD;
             gestational hypertension, preeclampsia, eclampsia, gestational diabetes, or diabetes&#xD;
             mellitus (type 1 or 2) based on diagnosis codes in the EMR&#xD;
&#xD;
          5. Has online access through smartphone or computer and has email address&#xD;
&#xD;
          6. Ability to read and provide informed consent to participate in the study&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Delivered prior to 32 weeks gestation in the EMR&#xD;
&#xD;
          2. Documentation of fetal demise or neonatal demise in the EMR&#xD;
&#xD;
          3. Currently pregnant or planning to get pregnant within the next 5 months&#xD;
&#xD;
          4. Does not speak English&#xD;
&#xD;
          5. Answers yes to any of the following questions:&#xD;
&#xD;
               -  Are you currently participating in any other weight loss or physical activity&#xD;
                  studies?&#xD;
&#xD;
               -  Do you have any medical conditions or other reasons why you could not participate&#xD;
                  in a 16-week weight loss or physical activity program?&#xD;
&#xD;
          6. Participants will be excluded after completing the run-in period if they do not&#xD;
             complete the daily food log or their baseline BMI is &lt; 27 kg/m2&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Jennifer Lewey, MD MPH</last_name>
    <phone>215-662-7700</phone>
    <email>jennifer.lewey@pennmedicine.upenn.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Valerie Riis, MS</last_name>
    <phone>215-498-9099</phone>
    <email>valerie.riis@pennmedicine.upenn.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University of Pennsylvania</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19104</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jennifer Lewey, MD</last_name>
      <email>jennifer.lewey@pennmedicine.upenn.edu</email>
    </contact>
    <contact_backup>
      <last_name>Valerie Riis</last_name>
      <email>valerie.riis@pennmedicine.upenn.edu</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>May 20, 2021</study_first_submitted>
  <study_first_submitted_qc>June 3, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">June 7, 2021</study_first_posted>
  <last_update_submitted>September 22, 2021</last_update_submitted>
  <last_update_submitted_qc>September 22, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 23, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Pennsylvania</investigator_affiliation>
    <investigator_full_name>Jennifer Lewey, MD, MPH</investigator_full_name>
    <investigator_title>Assistant Professor of Medicine</investigator_title>
  </responsible_party>
  <keyword>weight loss</keyword>
  <keyword>postpartum period</keyword>
  <keyword>hypertension in pregnancy</keyword>
  <keyword>cardiovascular risk reduction</keyword>
  <keyword>diabetes prevention program</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pre-Eclampsia</mesh_term>
    <mesh_term>Hypertension, Pregnancy-Induced</mesh_term>
    <mesh_term>Pregnancy in Diabetics</mesh_term>
    <mesh_term>Hypertension</mesh_term>
    <mesh_term>Body Weight</mesh_term>
    <mesh_term>Weight Loss</mesh_term>
    <mesh_term>Gestational Weight Gain</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

